Sign In
Buy ANIP
$75.23
+0.580 (+0.777%)
At Close: Jun 03, 2026
ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance
06:50am, Friday, 09'th May 2025
BAUDETTE, Minn., May 09, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the first quarter ended Ma
ANI Pharmaceuticals: A Short-Term Buying Opportunity
05:43am, Tuesday, 06'th May 2025
ANIP is expected to raise 2025 guidance due to FDA approval and launch of TEZRULY and INZIRQO, addressing unmet needs for dysphagic patients. Both drugs are patent protected until 2042 and offer new f
ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?
01:15pm, Monday, 05'th May 2025
ANIP's first-quarter 2025 revenues are likely to have been driven by increased sales of its lead product, Cortrophin Gel, and other rare disease products.
ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?
10:15am, Monday, 05'th May 2025
ANI (ANIP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Demonstrated Dose Dependent Effect in EAU Presented in a podium presentation at The Association for Research in Vision and Ophthalmology (ARVO) 2025 annual meeting PRINCETON, N.J., May 05, 2025 (GLOBE
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Friday, 02'nd May 2025
ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Reasons Growth Investors Will Love ANI (ANIP)
01:45pm, Friday, 25'th Apr 2025
ANI (ANIP) could produce exceptional returns because of its solid growth attributes.
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?
10:46am, Wednesday, 23'rd Apr 2025
Here is how ANI Pharmaceuticals (ANIP) and Agenus (AGEN) have performed compared to their sector so far this year.
Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue
09:30am, Wednesday, 23'rd Apr 2025
It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Stride, 908 Devices, & Contango are well-poised to gain.
5 Stocks With Recent Price Strength Amid Tariff-Led Volatility
07:05am, Wednesday, 23'rd Apr 2025
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are HRTG, MRX, KINS, ANIP, HCI.
4 Stocks Trading Near 52-Week High With Room to Rise Further
09:25am, Tuesday, 22'nd Apr 2025
Investors target stocks that have been on a bullish run lately. Stocks like ANIP, HRTG, AVA and EXC are seeing price strength and the momentum is likely to continue.
ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out?
10:15am, Thursday, 17'th Apr 2025
ANI (ANIP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)
01:45pm, Wednesday, 09'th Apr 2025
ANI (ANIP) could produce exceptional returns because of its solid growth attributes.
Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?
01:15pm, Wednesday, 09'th Apr 2025
ANI (ANIP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Wednesday, 09'th Apr 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
